Semaglutide weight management injections are used as part of a weight loss plan. Semaglutide injections are delivered beneath the surface of the skin (subcutaneously) for chronic weight management in adults with obesity (BMI >30) or who are overweight (BMI >27). Semaglutide mimics a glucagon-like peptide hormone called GLP-1, which slows the movement of food from the stomach into the small intestine, helping to reduce appetite and increase satisfaction after eating. Additional treatment benefits associated with Semaglutide weight management may include: improved A1C and blood sugar levels by increasing insulin (a hormone that lowers blood sugar levels) and inhibiting glucagon (a hormone that raises blood sugar); improved blood pressure; reduced risk of major adverse cardiovascular events.

Reported Side Effects May Include: nausea, vomiting, diarrhea, indigestion, injection site irritation, abdominal pain, constipation, fatigue, and dizziness. Multiple injections will be needed over the course of months to achieve desired results. Dosing adjustments will be titrated by your treatment provider based on your body’s response to Semaglutide and any side effects you’re experiencing.